APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pregabalin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pregabalin Market Analysis and Forecast 2026-2032

19 December 2025218 pages

Choose your research edition.

Industry ResearchPregabalin Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Pregabalin Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Pregabalin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pregabalin Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Pregabalin Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Pregabalin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pregabalin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pregabalin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pregabalin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pregabalin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pregabalin include Zhejiang Huahai Pharmaceutical, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, Changzhou Pharmaceutical Factory (CPF), ZCL Chemicals, Vasudha Pharma Chem, Srini Pharmaceuticals, Olon S.p.A. and Maps Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pregabalin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pregabalin, also provides the sales of main regions and countries. Of the upcoming market potential for Pregabalin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pregabalin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pregabalin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pregabalin sales, projected growth trends, production technology, application and end-user industry.

Pregabalin Segment by Company

Zhejiang Huahai Pharmaceutical

Teva Pharmaceutical Industries

Sun Pharmaceutical Industries

Changzhou Pharmaceutical Factory (CPF)

ZCL Chemicals

Vasudha Pharma Chem

Srini Pharmaceuticals

Olon S.p.A.

Maps Laboratories

Laurus Labs

Hikal

Glenmark Life Sciences

Dongbang FTL

Divi’s Laboratories

Divi’s Laboratories

CTX Life Sciences

Chemo Iberica

Bazayan

BAL Pharma

Aurobindo Pharma

ARITE Pharmaceutical

Angels Pharma

Almelo Pvt. Ltd.

AASraw Biochemical Technology

Pregabalin Segment by Type

Capsule

Oral Solution

Tablet

Pregabalin Segment by Application

Hospitals

Clinics

Others

Pregabalin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pregabalin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pregabalin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pregabalin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pregabalin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pregabalin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pregabalin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pregabalin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Capsule Major Manufacturers Table 3. Oral Solution Major Manufacturers Table 4. Tablet Major Manufacturers Table 5. Global Pregabalin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospitals Major Manufacturers Table 7. Clinics Major Manufacturers Table 8. Others Major Manufacturers Table 9. Pregabalin Industry Trends Table 10. Pregabalin Industry Drivers Table 11. Pregabalin Industry Opportunities and Challenges Table 12. Pregabalin Industry Restraints Table 13. Global Pregabalin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Pregabalin Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Pregabalin Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Pregabalin Revenue Market Share by Region (2021-2026) Table 17. Global Pregabalin Revenue Market Share by Region (2027-2032) Table 18. Global Pregabalin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 19. Global Pregabalin Sales by Region (2021-2026) & (W Units) Table 20. Global Pregabalin Sales by Region (2027-2032) & (W Units) Table 21. Global Pregabalin Sales Market Share by Region (2021-2026) Table 22. Global Pregabalin Sales Market Share by Region (2027-2032) Table 23. Global Pregabalin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Pregabalin Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Pregabalin Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Pregabalin Sales Market Share by Manufacturers (2021-2026) Table 27. Global Pregabalin Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Pregabalin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Pregabalin Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Pregabalin Manufacturers, Product Type & Application Table 31. Global Pregabalin Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Pregabalin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Pregabalin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pregabalin Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Pregabalin Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Pregabalin Revenue Market Share by Type (2021-2026) Table 38. Global Pregabalin Revenue Market Share by Type (2027-2032) Table 39. Global Pregabalin Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 40. Global Pregabalin Sales by Type (2021-2026) & (W Units) Table 41. Global Pregabalin Sales by Type (2027-2032) & (W Units) Table 42. Global Pregabalin Sales Market Share by Type (2021-2026) Table 43. Global Pregabalin Sales Market Share by Type (2027-2032) Table 44. Global Pregabalin Price by Type (2021-2026) & (US$/Unit) Table 45. Global Pregabalin Price by Type (2027-2032) & (US$/Unit) Table 46. Global Pregabalin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Pregabalin Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Pregabalin Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Pregabalin Revenue Market Share by Application (2021-2026) Table 50. Global Pregabalin Revenue Market Share by Application (2027-2032) Table 51. Global Pregabalin Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 52. Global Pregabalin Sales by Application (2021-2026) & (W Units) Table 53. Global Pregabalin Sales by Application (2027-2032) & (W Units) Table 54. Global Pregabalin Sales Market Share by Application (2021-2026) Table 55. Global Pregabalin Sales Market Share by Application (2027-2032) Table 56. Global Pregabalin Price by Application (2021-2026) & (US$/Unit) Table 57. Global Pregabalin Price by Application (2027-2032) & (US$/Unit) Table 58. Zhejiang Huahai Pharmaceutical Company Information Table 59. Zhejiang Huahai Pharmaceutical Business Overview Table 60. Zhejiang Huahai Pharmaceutical Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Zhejiang Huahai Pharmaceutical Pregabalin Product Portfolio Table 62. Zhejiang Huahai Pharmaceutical Recent Development Table 63. Teva Pharmaceutical Industries Company Information Table 64. Teva Pharmaceutical Industries Business Overview Table 65. Teva Pharmaceutical Industries Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Teva Pharmaceutical Industries Pregabalin Product Portfolio Table 67. Teva Pharmaceutical Industries Recent Development Table 68. Sun Pharmaceutical Industries Company Information Table 69. Sun Pharmaceutical Industries Business Overview Table 70. Sun Pharmaceutical Industries Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Sun Pharmaceutical Industries Pregabalin Product Portfolio Table 72. Sun Pharmaceutical Industries Recent Development Table 73. Changzhou Pharmaceutical Factory (CPF) Company Information Table 74. Changzhou Pharmaceutical Factory (CPF) Business Overview Table 75. Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Changzhou Pharmaceutical Factory (CPF) Pregabalin Product Portfolio Table 77. Changzhou Pharmaceutical Factory (CPF) Recent Development Table 78. ZCL Chemicals Company Information Table 79. ZCL Chemicals Business Overview Table 80. ZCL Chemicals Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. ZCL Chemicals Pregabalin Product Portfolio Table 82. ZCL Chemicals Recent Development Table 83. Vasudha Pharma Chem Company Information Table 84. Vasudha Pharma Chem Business Overview Table 85. Vasudha Pharma Chem Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Vasudha Pharma Chem Pregabalin Product Portfolio Table 87. Vasudha Pharma Chem Recent Development Table 88. Srini Pharmaceuticals Company Information Table 89. Srini Pharmaceuticals Business Overview Table 90. Srini Pharmaceuticals Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Srini Pharmaceuticals Pregabalin Product Portfolio Table 92. Srini Pharmaceuticals Recent Development Table 93. Olon S.p.A. Company Information Table 94. Olon S.p.A. Business Overview Table 95. Olon S.p.A. Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Olon S.p.A. Pregabalin Product Portfolio Table 97. Olon S.p.A. Recent Development Table 98. Maps Laboratories Company Information Table 99. Maps Laboratories Business Overview Table 100. Maps Laboratories Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Maps Laboratories Pregabalin Product Portfolio Table 102. Maps Laboratories Recent Development Table 103. Laurus Labs Company Information Table 104. Laurus Labs Business Overview Table 105. Laurus Labs Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Laurus Labs Pregabalin Product Portfolio Table 107. Laurus Labs Recent Development Table 108. Hikal Company Information Table 109. Hikal Business Overview Table 110. Hikal Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Hikal Pregabalin Product Portfolio Table 112. Hikal Recent Development Table 113. Glenmark Life Sciences Company Information Table 114. Glenmark Life Sciences Business Overview Table 115. Glenmark Life Sciences Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Glenmark Life Sciences Pregabalin Product Portfolio Table 117. Glenmark Life Sciences Recent Development Table 118. Dongbang FTL Company Information Table 119. Dongbang FTL Business Overview Table 120. Dongbang FTL Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Dongbang FTL Pregabalin Product Portfolio Table 122. Dongbang FTL Recent Development Table 123. Divi’s Laboratories Company Information Table 124. Divi’s Laboratories Business Overview Table 125. Divi’s Laboratories Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Divi’s Laboratories Pregabalin Product Portfolio Table 127. Divi’s Laboratories Recent Development Table 128. Divi’s Laboratories Company Information Table 129. Divi’s Laboratories Business Overview Table 130. Divi’s Laboratories Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Divi’s Laboratories Pregabalin Product Portfolio Table 132. Divi’s Laboratories Recent Development Table 133. CTX Life Sciences Company Information Table 134. CTX Life Sciences Business Overview Table 135. CTX Life Sciences Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. CTX Life Sciences Pregabalin Product Portfolio Table 137. CTX Life Sciences Recent Development Table 138. Chemo Iberica Company Information Table 139. Chemo Iberica Business Overview Table 140. Chemo Iberica Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Chemo Iberica Pregabalin Product Portfolio Table 142. Chemo Iberica Recent Development Table 143. Bazayan Company Information Table 144. Bazayan Business Overview Table 145. Bazayan Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Bazayan Pregabalin Product Portfolio Table 147. Bazayan Recent Development Table 148. BAL Pharma Company Information Table 149. BAL Pharma Business Overview Table 150. BAL Pharma Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. BAL Pharma Pregabalin Product Portfolio Table 152. BAL Pharma Recent Development Table 153. Aurobindo Pharma Company Information Table 154. Aurobindo Pharma Business Overview Table 155. Aurobindo Pharma Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. Aurobindo Pharma Pregabalin Product Portfolio Table 157. Aurobindo Pharma Recent Development Table 158. ARITE Pharmaceutical Company Information Table 159. ARITE Pharmaceutical Business Overview Table 160. ARITE Pharmaceutical Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 161. ARITE Pharmaceutical Pregabalin Product Portfolio Table 162. ARITE Pharmaceutical Recent Development Table 163. Angels Pharma Company Information Table 164. Angels Pharma Business Overview Table 165. Angels Pharma Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 166. Angels Pharma Pregabalin Product Portfolio Table 167. Angels Pharma Recent Development Table 168. Almelo Pvt. Ltd. Company Information Table 169. Almelo Pvt. Ltd. Business Overview Table 170. Almelo Pvt. Ltd. Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 171. Almelo Pvt. Ltd. Pregabalin Product Portfolio Table 172. Almelo Pvt. Ltd. Recent Development Table 173. AASraw Biochemical Technology Company Information Table 174. AASraw Biochemical Technology Business Overview Table 175. AASraw Biochemical Technology Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 176. AASraw Biochemical Technology Pregabalin Product Portfolio Table 177. AASraw Biochemical Technology Recent Development Table 178. North America Pregabalin Revenue by Type (2021-2026) & (US$ Million) Table 179. North America Pregabalin Revenue by Type (2027-2032) & (US$ Million) Table 180. North America Pregabalin Sales by Type (2021-2026) & (W Units) Table 181. North America Pregabalin Sales by Type (2027-2032) & (W Units) Table 182. North America Pregabalin Sales Price by Type (2021-2026) & (US$/Unit) Table 183. North America Pregabalin Sales Price by Type (2027-2032) & (US$/Unit) Table 184. North America Pregabalin Revenue by Application (2021-2026) & (US$ Million) Table 185. North America Pregabalin Revenue by Application (2027-2032) & (US$ Million) Table 186. North America Pregabalin Sales by Application (2021-2026) & (W Units) Table 187. North America Pregabalin Sales by Application (2027-2032) & (W Units) Table 188. North America Pregabalin Sales Price by Application (2021-2026) & (US$/Unit) Table 189. North America Pregabalin Sales Price by Application (2027-2032) & (US$/Unit) Table 190. North America Pregabalin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. North America Pregabalin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. North America Pregabalin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. North America Pregabalin Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 194. North America Pregabalin Sales by Country (2021-2026) & (W Units) Table 195. North America Pregabalin Sales by Country (2027-2032) & (W Units) Table 196. North America Pregabalin Sales Price by Country (2021-2026) & (US$/Unit) Table 197. North America Pregabalin Sales Price by Country (2027-2032) & (US$/Unit) Table 198. United States Pregabalin Revenue (2021-2032) & (US$ Million) Table 199. Canada Pregabalin Revenue (2021-2032) & (US$ Million) Table 200. Europe Pregabalin Revenue by Type (2021-2026) & (US$ Million) Table 201. Europe Pregabalin Revenue by Type (2027-2032) & (US$ Million) Table 202. Europe Pregabalin Sales by Type (2021-2026) & (W Units) Table 203. Europe Pregabalin Sales by Type (2027-2032) & (W Units) Table 204. Europe Pregabalin Sales Price by Type (2021-2026) & (US$/Unit) Table 205. Europe Pregabalin Sales Price by Type (2027-2032) & (US$/Unit) Table 206. Europe Pregabalin Revenue by Application (2021-2026) & (US$ Million) Table 207. Europe Pregabalin Revenue by Application (2027-2032) & (US$ Million) Table 208. Europe Pregabalin Sales by Application (2021-2026) & (W Units) Table 209. Europe Pregabalin Sales by Application (2027-2032) & (W Units) Table 210. Europe Pregabalin Sales Price by Application (2021-2026) & (US$/Unit) Table 211. Europe Pregabalin Sales Price by Application (2027-2032) & (US$/Unit) Table 212. Europe Pregabalin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 213. Europe Pregabalin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 214. Europe Pregabalin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 215. Europe Pregabalin Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 216. Europe Pregabalin Sales by Country (2021-2026) & (W Units) Table 217. Europe Pregabalin Sales by Country (2027-2032) & (W Units) Table 218. Europe Pregabalin Sales Price by Country (2021-2026) & (US$/Unit) Table 219. Europe Pregabalin Sales Price by Country (2027-2032) & (US$/Unit) Table 220. Germany Pregabalin Revenue (2021-2032) & (US$ Million) Table 221. France Pregabalin Revenue (2021-2032) & (US$ Million) Table 222. U.K. Pregabalin Revenue (2021-2032) & (US$ Million) Table 223. Italy Pregabalin Revenue (2021-2032) & (US$ Million) Table 224. Netherlands Pregabalin Revenue (2021-2032) & (US$ Million) Table 225. Nordic Countries Pregabalin Revenue (2021-2032) & (US$ Million) Table 226. China Pregabalin Revenue by Type (2021-2026) & (US$ Million) Table 227. China Pregabalin Revenue by Type (2027-2032) & (US$ Million) Table 228. China Pregabalin Sales by Type (2021-2026) & (W Units) Table 229. China Pregabalin Sales by Type (2027-2032) & (W Units) Table 230. China Pregabalin Sales Price by Type (2021-2026) & (US$/Unit) Table 231. China Pregabalin Sales Price by Type (2027-2032) & (US$/Unit) Table 232. China Pregabalin Revenue by Application (2021-2026) & (US$ Million) Table 233. China Pregabalin Revenue by Application (2027-2032) & (US$ Million) Table 234. China Pregabalin Sales by Application (2021-2026) & (W Units) Table 235. China Pregabalin Sales by Application (2027-2032) & (W Units) Table 236. China Pregabalin Sales Price by Application (2021-2026) & (US$/Unit) Table 237. China Pregabalin Sales Price by Application (2027-2032) & (US$/Unit) Table 238. Asia Pregabalin Revenue by Type (2021-2026) & (US$ Million) Table 239. Asia Pregabalin Revenue by Type (2027-2032) & (US$ Million) Table 240. Asia Pregabalin Sales by Type (2021-2026) & (W Units) Table 241. Asia Pregabalin Sales by Type (2027-2032) & (W Units) Table 242. Asia Pregabalin Sales Price by Type (2021-2026) & (US$/Unit) Table 243. Asia Pregabalin Sales Price by Type (2027-2032) & (US$/Unit) Table 244. Asia Pregabalin Revenue by Application (2021-2026) & (US$ Million) Table 245. Asia Pregabalin Revenue by Application (2027-2032) & (US$ Million) Table 246. Asia Pregabalin Sales by Application (2021-2026) & (W Units) Table 247. Asia Pregabalin Sales by Application (2027-2032) & (W Units) Table 248. Asia Pregabalin Sales Price by Application (2021-2026) & (US$/Unit) Table 249. Asia Pregabalin Sales Price by Application (2027-2032) & (US$/Unit) Table 250. Asia Pregabalin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 251. Asia Pregabalin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 252. Asia Pregabalin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 253. Asia Pregabalin Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 254. Asia Pregabalin Sales by Country (2021-2026) & (W Units) Table 255. Asia Pregabalin Sales by Country (2027-2032) & (W Units) Table 256. Asia Pregabalin Sales Price by Country (2021-2026) & (US$/Unit) Table 257. Asia Pregabalin Sales Price by Country (2027-2032) & (US$/Unit) Table 258. Japan Pregabalin Revenue (2021-2032) & (US$ Million) Table 259. South Korea Pregabalin Revenue (2021-2032) & (US$ Million) Table 260. India Pregabalin Revenue (2021-2032) & (US$ Million) Table 261. Australia Pregabalin Revenue (2021-2032) & (US$ Million) Table 262. China Taiwan Pregabalin Revenue (2021-2032) & (US$ Million) Table 263. Southeast Asia Pregabalin Revenue (2021-2032) & (US$ Million) Table 264. SAMEA Pregabalin Revenue by Type (2021-2026) & (US$ Million) Table 265. SAMEA Pregabalin Revenue by Type (2027-2032) & (US$ Million) Table 266. SAMEA Pregabalin Sales by Type (2021-2026) & (W Units) Table 267. SAMEA Pregabalin Sales by Type (2027-2032) & (W Units) Table 268. SAMEA Pregabalin Sales Price by Type (2021-2026) & (US$/Unit) Table 269. SAMEA Pregabalin Sales Price by Type (2027-2032) & (US$/Unit) Table 270. SAMEA Pregabalin Revenue by Application (2021-2026) & (US$ Million) Table 271. SAMEA Pregabalin Revenue by Application (2027-2032) & (US$ Million) Table 272. SAMEA Pregabalin Sales by Application (2021-2026) & (W Units) Table 273. SAMEA Pregabalin Sales by Application (2027-2032) & (W Units) Table 274. SAMEA Pregabalin Sales Price by Application (2021-2026) & (US$/Unit) Table 275. SAMEA Pregabalin Sales Price by Application (2027-2032) & (US$/Unit) Table 276. SAMEA Pregabalin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 277. SAMEA Pregabalin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 278. SAMEA Pregabalin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 279. SAMEA Pregabalin Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 280. SAMEA Pregabalin Sales by Country (2021-2026) & (W Units) Table 281. SAMEA Pregabalin Sales by Country (2027-2032) & (W Units) Table 282. SAMEA Pregabalin Sales Price by Country (2021-2026) & (US$/Unit) Table 283. SAMEA Pregabalin Sales Price by Country (2027-2032) & (US$/Unit) Table 284. Brazil Pregabalin Revenue (2021-2032) & (US$ Million) Table 285. Argentina Pregabalin Revenue (2021-2032) & (US$ Million) Table 286. Chile Pregabalin Revenue (2021-2032) & (US$ Million) Table 287. Colombia Pregabalin Revenue (2021-2032) & (US$ Million) Table 288. Peru Pregabalin Revenue (2021-2032) & (US$ Million) Table 289. Saudi Arabia Pregabalin Revenue (2021-2032) & (US$ Million) Table 290. Israel Pregabalin Revenue (2021-2032) & (US$ Million) Table 291. UAE Pregabalin Revenue (2021-2032) & (US$ Million) Table 292. Turkey Pregabalin Revenue (2021-2032) & (US$ Million) Table 293. Iran Pregabalin Revenue (2021-2032) & (US$ Million) Table 294. Egypt Pregabalin Revenue (2021-2032) & (US$ Million) Table 295. Key Raw Materials Table 296. Raw Materials Key Suppliers Table 297. Pregabalin Distributors List Table 298. Pregabalin Customers List Table 299. Research Programs/Design for This Report Table 300. Authors List of This Report Table 301. Secondary Sources Table 302. Primary Sources List of Figures Figure 1. Pregabalin Image Figure 2. Global Pregabalin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pregabalin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Capsule Image Figure 5. Oral Solution Image Figure 6. Tablet Image Figure 7. Global Pregabalin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Pregabalin Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Clinics Image Figure 11. Others Image Figure 12. Global Pregabalin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pregabalin Revenue (2021-2032) & (US$ Million) Figure 14. Global Pregabalin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Pregabalin Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Pregabalin Revenue Market Share by Region (2021-2032) Figure 17. Global Pregabalin Sales (2021-2032) & (W Units) Figure 18. Global Pregabalin Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 19. Global Pregabalin Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Pregabalin Sales YoY (2021-2032) & (W Units) Figure 21. Europe Pregabalin Sales YoY (2021-2032) & (W Units) Figure 22. China Pregabalin Sales YoY (2021-2032) & (W Units) Figure 23. Asia (Excluding China) Pregabalin Sales YoY (2021-2032) & (W Units) Figure 24. South America, Middle East and Africa Pregabalin Sales YoY (2021-2032) & (W Units) Figure 25. Global Pregabalin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Pregabalin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Pregabalin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Pregabalin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Pregabalin Revenue Market Share by Type (2021-2032) Figure 31. Global Pregabalin Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 32. Global Pregabalin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Pregabalin Sales Market Share by Type (2021-2032) Figure 34. Global Pregabalin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Pregabalin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Pregabalin Revenue Market Share by Application (2021-2032) Figure 37. Global Pregabalin Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 38. Global Pregabalin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Pregabalin Sales Market Share by Application (2021-2032) Figure 40. North America Pregabalin Revenue Share by Type (2021-2032) Figure 41. North America Pregabalin Sales Share by Type (2021-2032) Figure 42. North America Pregabalin Revenue Share by Application (2021-2032) Figure 43. North America Pregabalin Sales Share by Application (2021-2032) Figure 44. North America Pregabalin Revenue Share by Country (2021-2032) Figure 45. North America Pregabalin Sales Share by Country (2021-2032) Figure 46. Europe Pregabalin Revenue Share by Type (2021-2032) Figure 47. Europe Pregabalin Sales Share by Type (2021-2032) Figure 48. Europe Pregabalin Revenue Share by Application (2021-2032) Figure 49. Europe Pregabalin Sales Share by Application (2021-2032) Figure 50. Europe Pregabalin Revenue Share by Country (2021-2032) Figure 51. Europe Pregabalin Sales Share by Country (2021-2032) Figure 52. China Pregabalin Revenue Share by Type (2021-2032) Figure 53. China Pregabalin Sales Share by Type (2021-2032) Figure 54. China Pregabalin Revenue Share by Application (2021-2032) Figure 55. China Pregabalin Sales Share by Application (2021-2032) Figure 56. Asia Pregabalin Revenue Share by Type (2021-2032) Figure 57. Asia Pregabalin Sales Share by Type (2021-2032) Figure 58. Asia Pregabalin Revenue Share by Application (2021-2032) Figure 59. Asia Pregabalin Sales Share by Application (2021-2032) Figure 60. Asia Pregabalin Revenue Share by Country (2021-2032) Figure 61. Asia Pregabalin Sales Share by Country (2021-2032) Figure 62. SAMEA Pregabalin Revenue Share by Type (2021-2032) Figure 63. SAMEA Pregabalin Sales Share by Type (2021-2032) Figure 64. SAMEA Pregabalin Revenue Share by Application (2021-2032) Figure 65. SAMEA Pregabalin Sales Share by Application (2021-2032) Figure 66. SAMEA Pregabalin Revenue Share by Country (2021-2032) Figure 67. SAMEA Pregabalin Sales Share by Country (2021-2032) Figure 68. Pregabalin Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Pregabalin Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Oral Solution
  • Tablet
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Changzhou Pharmaceutical Factory (CPF)
  • ZCL Chemicals
  • Vasudha Pharma Chem
  • Srini Pharmaceuticals
  • Olon S.p.A.
  • Maps Laboratories
  • Laurus Labs
  • Hikal
  • Glenmark Life Sciences
  • Dongbang FTL
  • Divi’s Laboratories
  • Divi’s Laboratories
  • CTX Life Sciences
  • Chemo Iberica
  • Bazayan
  • BAL Pharma
  • Aurobindo Pharma
  • ARITE Pharmaceutical
  • Angels Pharma
  • Almelo Pvt. Ltd.
  • AASraw Biochemical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pregabalin Market by Type
  3. 1.2.1 Global Pregabalin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Capsule
  5. 1.2.3 Oral Solution
  6. 1.2.4 Tablet
  7. 1.3 Pregabalin Market by Application
  8. 1.3.1 Global Pregabalin Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Clinics
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pregabalin Market Dynamics
  1. 2.1 Pregabalin Industry Trends
  2. 2.2 Pregabalin Industry Drivers
  3. 2.3 Pregabalin Industry Opportunities and Challenges
  4. 2.4 Pregabalin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pregabalin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pregabalin Revenue by Region
  3. 3.2.1 Global Pregabalin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pregabalin Revenue by Region (2021-2026)
  5. 3.2.3 Global Pregabalin Revenue by Region (2027-2032)
  6. 3.2.4 Global Pregabalin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pregabalin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pregabalin Sales by Region
  9. 3.4.1 Global Pregabalin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pregabalin Sales by Region (2021-2026)
  11. 3.4.3 Global Pregabalin Sales by Region (2027-2032)
  12. 3.4.4 Global Pregabalin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pregabalin Revenue by Manufacturers
  2. 4.1.1 Global Pregabalin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pregabalin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pregabalin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pregabalin Sales by Manufacturers
  6. 4.2.1 Global Pregabalin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pregabalin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pregabalin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pregabalin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pregabalin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pregabalin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pregabalin Manufacturers, Product Type & Application
  13. 4.7 Global Pregabalin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pregabalin Market CR5 and HHI
  16. 4.8.2 2025 Pregabalin Tier 1, Tier 2, and Tier 3
5 Pregabalin Market by Type
  1. 5.1 Global Pregabalin Revenue by Type
  2. 5.1.1 Global Pregabalin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pregabalin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pregabalin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pregabalin Sales by Type
  6. 5.2.1 Global Pregabalin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pregabalin Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Pregabalin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pregabalin Price by Type
6 Pregabalin Market by Application
  1. 6.1 Global Pregabalin Revenue by Application
  2. 6.1.1 Global Pregabalin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pregabalin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pregabalin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pregabalin Sales by Application
  6. 6.2.1 Global Pregabalin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pregabalin Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Pregabalin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pregabalin Price by Application
7 Company Profiles
  1. 7.1 Zhejiang Huahai Pharmaceutical
  2. 7.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 7.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 7.1.3 Zhejiang Huahai Pharmaceutical Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zhejiang Huahai Pharmaceutical Pregabalin Product Portfolio
  6. 7.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 7.2 Teva Pharmaceutical Industries
  8. 7.2.1 Teva Pharmaceutical Industries Company Information
  9. 7.2.2 Teva Pharmaceutical Industries Business Overview
  10. 7.2.3 Teva Pharmaceutical Industries Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Teva Pharmaceutical Industries Pregabalin Product Portfolio
  12. 7.2.5 Teva Pharmaceutical Industries Recent Developments
  13. 7.3 Sun Pharmaceutical Industries
  14. 7.3.1 Sun Pharmaceutical Industries Company Information
  15. 7.3.2 Sun Pharmaceutical Industries Business Overview
  16. 7.3.3 Sun Pharmaceutical Industries Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sun Pharmaceutical Industries Pregabalin Product Portfolio
  18. 7.3.5 Sun Pharmaceutical Industries Recent Developments
  19. 7.4 Changzhou Pharmaceutical Factory (CPF)
  20. 7.4.1 Changzhou Pharmaceutical Factory (CPF) Company Information
  21. 7.4.2 Changzhou Pharmaceutical Factory (CPF) Business Overview
  22. 7.4.3 Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Changzhou Pharmaceutical Factory (CPF) Pregabalin Product Portfolio
  24. 7.4.5 Changzhou Pharmaceutical Factory (CPF) Recent Developments
  25. 7.5 ZCL Chemicals
  26. 7.5.1 ZCL Chemicals Company Information
  27. 7.5.2 ZCL Chemicals Business Overview
  28. 7.5.3 ZCL Chemicals Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 ZCL Chemicals Pregabalin Product Portfolio
  30. 7.5.5 ZCL Chemicals Recent Developments
  31. 7.6 Vasudha Pharma Chem
  32. 7.6.1 Vasudha Pharma Chem Company Information
  33. 7.6.2 Vasudha Pharma Chem Business Overview
  34. 7.6.3 Vasudha Pharma Chem Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Vasudha Pharma Chem Pregabalin Product Portfolio
  36. 7.6.5 Vasudha Pharma Chem Recent Developments
  37. 7.7 Srini Pharmaceuticals
  38. 7.7.1 Srini Pharmaceuticals Company Information
  39. 7.7.2 Srini Pharmaceuticals Business Overview
  40. 7.7.3 Srini Pharmaceuticals Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Srini Pharmaceuticals Pregabalin Product Portfolio
  42. 7.7.5 Srini Pharmaceuticals Recent Developments
  43. 7.8 Olon S.p.A.
  44. 7.8.1 Olon S.p.A. Company Information
  45. 7.8.2 Olon S.p.A. Business Overview
  46. 7.8.3 Olon S.p.A. Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Olon S.p.A. Pregabalin Product Portfolio
  48. 7.8.5 Olon S.p.A. Recent Developments
  49. 7.9 Maps Laboratories
  50. 7.9.1 Maps Laboratories Company Information
  51. 7.9.2 Maps Laboratories Business Overview
  52. 7.9.3 Maps Laboratories Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Maps Laboratories Pregabalin Product Portfolio
  54. 7.9.5 Maps Laboratories Recent Developments
  55. 7.10 Laurus Labs
  56. 7.10.1 Laurus Labs Company Information
  57. 7.10.2 Laurus Labs Business Overview
  58. 7.10.3 Laurus Labs Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Laurus Labs Pregabalin Product Portfolio
  60. 7.10.5 Laurus Labs Recent Developments
  61. 7.11 Hikal
  62. 7.11.1 Hikal Company Information
  63. 7.11.2 Hikal Business Overview
  64. 7.11.3 Hikal Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Hikal Pregabalin Product Portfolio
  66. 7.11.5 Hikal Recent Developments
  67. 7.12 Glenmark Life Sciences
  68. 7.12.1 Glenmark Life Sciences Company Information
  69. 7.12.2 Glenmark Life Sciences Business Overview
  70. 7.12.3 Glenmark Life Sciences Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Glenmark Life Sciences Pregabalin Product Portfolio
  72. 7.12.5 Glenmark Life Sciences Recent Developments
  73. 7.13 Dongbang FTL
  74. 7.13.1 Dongbang FTL Company Information
  75. 7.13.2 Dongbang FTL Business Overview
  76. 7.13.3 Dongbang FTL Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Dongbang FTL Pregabalin Product Portfolio
  78. 7.13.5 Dongbang FTL Recent Developments
  79. 7.14 Divi’s Laboratories
  80. 7.14.1 Divi’s Laboratories Company Information
  81. 7.14.2 Divi’s Laboratories Business Overview
  82. 7.14.3 Divi’s Laboratories Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Divi’s Laboratories Pregabalin Product Portfolio
  84. 7.14.5 Divi’s Laboratories Recent Developments
  85. 7.15 Divi’s Laboratories
  86. 7.15.1 Divi’s Laboratories Company Information
  87. 7.15.2 Divi’s Laboratories Business Overview
  88. 7.15.3 Divi’s Laboratories Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Divi’s Laboratories Pregabalin Product Portfolio
  90. 7.15.5 Divi’s Laboratories Recent Developments
  91. 7.16 CTX Life Sciences
  92. 7.16.1 CTX Life Sciences Company Information
  93. 7.16.2 CTX Life Sciences Business Overview
  94. 7.16.3 CTX Life Sciences Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 CTX Life Sciences Pregabalin Product Portfolio
  96. 7.16.5 CTX Life Sciences Recent Developments
  97. 7.17 Chemo Iberica
  98. 7.17.1 Chemo Iberica Company Information
  99. 7.17.2 Chemo Iberica Business Overview
  100. 7.17.3 Chemo Iberica Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Chemo Iberica Pregabalin Product Portfolio
  102. 7.17.5 Chemo Iberica Recent Developments
  103. 7.18 Bazayan
  104. 7.18.1 Bazayan Company Information
  105. 7.18.2 Bazayan Business Overview
  106. 7.18.3 Bazayan Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Bazayan Pregabalin Product Portfolio
  108. 7.18.5 Bazayan Recent Developments
  109. 7.19 BAL Pharma
  110. 7.19.1 BAL Pharma Company Information
  111. 7.19.2 BAL Pharma Business Overview
  112. 7.19.3 BAL Pharma Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 BAL Pharma Pregabalin Product Portfolio
  114. 7.19.5 BAL Pharma Recent Developments
  115. 7.20 Aurobindo Pharma
  116. 7.20.1 Aurobindo Pharma Company Information
  117. 7.20.2 Aurobindo Pharma Business Overview
  118. 7.20.3 Aurobindo Pharma Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Aurobindo Pharma Pregabalin Product Portfolio
  120. 7.20.5 Aurobindo Pharma Recent Developments
  121. 7.21 ARITE Pharmaceutical
  122. 7.21.1 ARITE Pharmaceutical Company Information
  123. 7.21.2 ARITE Pharmaceutical Business Overview
  124. 7.21.3 ARITE Pharmaceutical Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 ARITE Pharmaceutical Pregabalin Product Portfolio
  126. 7.21.5 ARITE Pharmaceutical Recent Developments
  127. 7.22 Angels Pharma
  128. 7.22.1 Angels Pharma Company Information
  129. 7.22.2 Angels Pharma Business Overview
  130. 7.22.3 Angels Pharma Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Angels Pharma Pregabalin Product Portfolio
  132. 7.22.5 Angels Pharma Recent Developments
  133. 7.23 Almelo Pvt. Ltd.
  134. 7.23.1 Almelo Pvt. Ltd. Company Information
  135. 7.23.2 Almelo Pvt. Ltd. Business Overview
  136. 7.23.3 Almelo Pvt. Ltd. Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Almelo Pvt. Ltd. Pregabalin Product Portfolio
  138. 7.23.5 Almelo Pvt. Ltd. Recent Developments
  139. 7.24 AASraw Biochemical Technology
  140. 7.24.1 AASraw Biochemical Technology Company Information
  141. 7.24.2 AASraw Biochemical Technology Business Overview
  142. 7.24.3 AASraw Biochemical Technology Pregabalin Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 AASraw Biochemical Technology Pregabalin Product Portfolio
  144. 7.24.5 AASraw Biochemical Technology Recent Developments
8 North America
  1. 8.1 North America Pregabalin Market Size by Type
  2. 8.1.1 North America Pregabalin Revenue by Type (2021-2032)
  3. 8.1.2 North America Pregabalin Sales by Type (2021-2032)
  4. 8.1.3 North America Pregabalin Price by Type (2021-2032)
  5. 8.2 North America Pregabalin Market Size by Application
  6. 8.2.1 North America Pregabalin Revenue by Application (2021-2032)
  7. 8.2.2 North America Pregabalin Sales by Application (2021-2032)
  8. 8.2.3 North America Pregabalin Price by Application (2021-2032)
  9. 8.3 North America Pregabalin Market Size by Country
  10. 8.3.1 North America Pregabalin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pregabalin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pregabalin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Pregabalin Market Size by Type
  2. 9.1.1 Europe Pregabalin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pregabalin Sales by Type (2021-2032)
  4. 9.1.3 Europe Pregabalin Price by Type (2021-2032)
  5. 9.2 Europe Pregabalin Market Size by Application
  6. 9.2.1 Europe Pregabalin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pregabalin Sales by Application (2021-2032)
  8. 9.2.3 Europe Pregabalin Price by Application (2021-2032)
  9. 9.3 Europe Pregabalin Market Size by Country
  10. 9.3.1 Europe Pregabalin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pregabalin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pregabalin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Pregabalin Market Size by Type
  2. 10.1.1 China Pregabalin Revenue by Type (2021-2032)
  3. 10.1.2 China Pregabalin Sales by Type (2021-2032)
  4. 10.1.3 China Pregabalin Price by Type (2021-2032)
  5. 10.2 China Pregabalin Market Size by Application
  6. 10.2.1 China Pregabalin Revenue by Application (2021-2032)
  7. 10.2.2 China Pregabalin Sales by Application (2021-2032)
  8. 10.2.3 China Pregabalin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pregabalin Market Size by Type
  2. 11.1.1 Asia Pregabalin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pregabalin Sales by Type (2021-2032)
  4. 11.1.3 Asia Pregabalin Price by Type (2021-2032)
  5. 11.2 Asia Pregabalin Market Size by Application
  6. 11.2.1 Asia Pregabalin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pregabalin Sales by Application (2021-2032)
  8. 11.2.3 Asia Pregabalin Price by Application (2021-2032)
  9. 11.3 Asia Pregabalin Market Size by Country
  10. 11.3.1 Asia Pregabalin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pregabalin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pregabalin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pregabalin Market Size by Type
  2. 12.1.1 SAMEA Pregabalin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pregabalin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pregabalin Price by Type (2021-2032)
  5. 12.2 SAMEA Pregabalin Market Size by Application
  6. 12.2.1 SAMEA Pregabalin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pregabalin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pregabalin Price by Application (2021-2032)
  9. 12.3 SAMEA Pregabalin Market Size by Country
  10. 12.3.1 SAMEA Pregabalin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pregabalin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pregabalin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pregabalin Value Chain Analysis
  2. 13.1.1 Pregabalin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pregabalin Production Mode & Process
  6. 13.2 Pregabalin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pregabalin Distributors
  9. 13.2.3 Pregabalin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst